Bill
A 1287
Bill A 1287 ensures insurance coverage for single source drugs, improving access and affordability for patients while promoting cost transparency and patient protections.
Bill A 1287 aims to establish regulations regarding the coverage of single source drugs by insurance providers. Single source drugs are medications that are produced by only one manufacturer and do not have generic alternatives. The intent of this bill is to ensure that patients have access to necessary medications without facing prohibitive costs due to lack of competition in the market.
While the specific text of the bill is not provided, the following key provisions are typically associated with legislation concerning drug coverage:
Insurance Coverage Requirements: The bill may mandate that insurance companies provide coverage for single source drugs, ensuring that patients can obtain these medications without excessive out-of-pocket costs.
Cost Transparency: The bill could include provisions for insurance companies to disclose the costs associated with single source drugs, promoting transparency for consumers.
Prior Authorization Processes: It may address the prior authorization requirements that insurance companies impose, potentially streamlining the process for patients needing these medications.
Patient Protections: The legislation might include protections for patients against sudden price increases or denials of coverage for medically necessary single source drugs.
Patients: Individuals who rely on single source drugs for their health conditions would benefit from improved access and affordability.
Insurance Companies: Insurers would need to adjust their policies and coverage plans to comply with the new requirements set forth by the bill.
Healthcare Providers: Physicians and pharmacists may need to adapt their practices in response to changes in insurance coverage and reimbursement for single source drugs.
Current Status: As of January 09, 2025, the bill has been referred to the Insurance Committee for further consideration.
Related Legislation: Bill A 1287 is part of a broader legislative context, with several related bills from prior sessions (A 4477, A 6130, A 4724, A 4131, A 4075, A 5273, A 4899, A 5032, A 4494) and a companion bill in the Senate (S 6168). This indicates ongoing legislative interest in the topic of drug coverage and insurance regulations.
Bill A 1287 represents an important step towards improving access to essential medications for patients who rely on single source drugs. By addressing insurance coverage and cost transparency, the bill seeks to alleviate financial burdens and ensure that patients receive the medications they need. As it progresses through the legislative process, stakeholders will be closely monitoring its developments and potential impacts on healthcare access.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
